TY  - JOUR
AU  - Suárez-García, Inés
AU  - Moreno, Cristina
AU  - Ruiz-Algueró, Marta
AU  - Pérez-Elías, María Jesús
AU  - Navarro, Marta
AU  - Díez Martínez, Marcos
AU  - Viciana, Pompeyo
AU  - Pérez-Martínez, Laura
AU  - Górgolas, Miguel
AU  - Amador, Concha
AU  - de Zárraga, Miguel Alberto
AU  - Jarrín, Inma
AU  - Cohort of the Spanish HIV/AIDS Research Network (CoRIS)
PY  - 2020
DO  - 10.1186/s12981-020-00302-2
UR  - http://hdl.handle.net/10668/15964
T2  - AIDS research and therapy
AB  - The aim of this study was to investigate the effectiveness and tolerability of the combination elvitegravir/cobicistat/tenofovir/emtricitabine plus darunavir (EVG/COB/TFV/FTC + DRV) in treatment-experienced patients from the cohort of the Spanish...
LA  - en
KW  - Cohort studies
KW  - Darunavir
KW  - HIV infection
KW  - Highly active antiretroviral therapy
KW  - Adult
KW  - Anti-HIV Agents
KW  - Cobicistat
KW  - Darunavir
KW  - Drug Therapy, Combination
KW  - Emtricitabine
KW  - Female
KW  - HIV Infections
KW  - HIV-1
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Quinolones
KW  - Spain
KW  - Tenofovir
KW  - Treatment Outcome
KW  - Viral Load
TI  - Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study.
TY  - research article
VL  - 17
ER  -